Background Localized scleroderma (LS) comprises a spectrum of sclerotic autoimmune
diseases primarily affecting the dermis. Various treatment modalities have been …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

Previous studies report the benefit of UVA1 phototherapy in treating acrosclerosis in patients
with systemic sclerosis. We carried out a retrospective study to examine the effectiveness of …

Background: Previous work has indicated that extracorporeal photochemotherapy (ECP)
may be a safe and effective treatment in patients with severe atopic dermatitis. Methods: We …

REPORT OF A CASE A 42-year-old woman who suffered for more than 2 years from
disseminated localized scleroderma (LS)(Figure 1) markedly improved during treatment with …

Extracorporeal photochemotherapy (extracorporeal photopheresis, ECP) is going to become
a new alternative in the treatment of cutaneous T cell lymphomas (CTCL), autoimmune …

Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

Systemic and localized scleroderma are difficult to manage diseases with no accepted gold
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …

Chronic graft‐versus‐host disease (GvHD) affects 50% of long‐term bone marrow transplant
survivors and remains a cause of major long‐term morbidity in these patients despite …